
Today marks 103 days to "IFEADIGO 2025", the 44th Annual International Scientific Conference of the Association of Community Pharmacists of Nigeria (ACPN), taking place from July 22 to 27, 2025, at the International Conference Center in Awka, Anambra State. As we approach this momentous event, let’s explore the groundbreaking advancements in the pharmaceutical sector within the state.
Did you know that Anambra State is pioneering a pharmaceutical distribution hub in Oba, Idemili South Local Government Area? This innovative initiative is designed to regulate drug sales and combat the pervasive issue of fake medicines in Nigeria. By establishing a central hub, Anambra aims to enhance the integrity of the pharmaceutical supply chain, ensuring that communities have access to safe and effective medications. This initiative is a significant step toward improving healthcare standards and protecting the health of the populace.
As the "Light of the Nation," Anambra State continues to showcase its commitment to health and innovation, positioning itself as a leader in the fight against counterfeit drugs. The upcoming "IFEADIGO 2025" conference, themed "Technology Integration and Personalized Care: The Future of Community Pharmacy Practice," will highlight such innovations and focus on leveraging technology to further enhance patient care and safety.
The term IFEADIGO translates to "light has come," representing the dawn of new ideas and practices in pharmacy that will illuminate the path toward improved healthcare. The conference will serve as a platform for sharing insights, strategies, and best practices among pharmacy professionals while fostering collaboration and inspiring a shared vision for the future.
As we count down to this pivotal event, it is essential to recognize the strides being made in Anambra's pharmaceutical sector. By championing initiatives like the distribution hub in Oba, the state is making significant contributions to the well-being of its citizens and setting a precedent for other regions in Nigeria.